Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome

Cardoso CC, Pereira AC, de Sales Marques C, Moraes MO.

Future Microbiol. 2011 May;6(5):533-49. doi: 10.2217/fmb.11.39.

Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease

Al-Sweidi S, Morissette M, Bourque M, Di Paolo T.

Neuropharmacology. 2011 Sep;61(4):583-91. doi: 10.1016/j.neuropharm.2011.04.031. Epub 2011 May 11.

Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected]

Ossola B, Schendzielorz N, Chen SH, Bird GS, Tuominen RK, Männistö PT, Hong JS.

Neuropharmacology. 2011 Sep;61(4):574-82. doi: 10.1016/j.neuropharm.2011.04.030. Epub 2011 May 11.

Piribedil-induced sleep attacks in patients without Parkinson disease: a case series

Gouraud A, Millaret A, Descotes J, Vial T; French Association of Regional Pharmacovigilance Centres.

Clin Neuropharmacol. 2011 May-Jun;34(3):104-7. doi: 10.1097/WNF.0b013e31821f0d8b.

Use of probiotics for the treatment of constipation in Parkinson's disease patients

Cassani E, Privitera G, Pezzoli G, Pusani C, Madio C, Iorio L, Barichella M.

Minerva Gastroenterol Dietol. 2011 Jun;57(2):117-21.

Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates

Collier TJ, Kanaan NM, Kordower JH.

Nat Rev Neurosci. 2011 Jun;12(6):359-66. doi: 10.1038/nrn3039. Epub 2011 May 18.

Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family

Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N, Threlfell S, Kooner G, Deacon RM, Bannerman DM, Bolam JP, Chandra SS, Cragg SJ, Wade-Martins R, Buchman VL.

J Neurosci. 2011 May 18;31(20):7264-74. doi: 10.1523/JNEUROSCI.6194-10.2011.

Impulse control disorders and dopaminergic treatments in Parkinson's disease

Villa C, Pascual-Sedano B, Pagonabarraga J, Kulisevsky J.

Rev Neurol (Paris). 2011 Nov;167(11):827-32. doi: 10.1016/j.neurol.2011.01.018. Epub 2011 May 18.

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, Dolan RJ, Hallett M.

Brain. 2011 May;134(Pt 5):1438-46. doi: 10.1093/brain/awr080.

The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI

MacDonald PA, MacDonald AA, Seergobin KN, Tamjeedi R, Ganjavi H, Provost JS, Monchi O.

Brain. 2011 May;134(Pt 5):1447-63. doi: 10.1093/brain/awr075.

Deep brain stimulation of the pedunculopontine nucleus in a patient with freezing of gait

Acar F, Acar G, Bir LS, Gedik B, Oğuzhanoğlu A.

Stereotact Funct Neurosurg. 2011;89(4):214-9. doi: 10.1159/000326617. Epub 2011 May 20.

Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases

Nakamura T, Lipton SA.

Cell Death Differ. 2011 Sep;18(9):1478-86. doi: 10.1038/cdd.2011.65. Epub 2011 May 20.

Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives

Cheung ZH, Ip NY.

J Neurochem. 2011 Aug;118(3):317-25. doi: 10.1111/j.1471-4159.2011.07314.x. Epub 2011 Jun 17.

Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report

Wu YF, Kan YS, Yang CH.

Gen Hosp Psychiatry. 2011 May-Jun;33(3):301.e7-8. doi: 10.1016/j.genhosppsych.2010.11.013. Epub 2011 Jan 8.

Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson's disease

Plowman EK, Kleim JA.

J Commun Disord. 2011 Sep-Oct;44(5):549-56. doi: 10.1016/j.jcomdis.2011.04.008. Epub 2011 Apr 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias